Cannabis News and Research

Latest Cannabis News and Research

Study identifies a 'window of impairment' caused by cannabis intoxication

A comprehensive analysis of 80 scientific studies has identified a 'window of impairment' of between three and 10 hours caused by moderate to high doses of the intoxicating component of cannabis, tetrahydrocannabinol (THC).

12 Apr 2021

Early cannabis use may increase risk of developing heart disease

Smoking cannabis when you're young may increase your risk of developing heart disease later, according to a recent University of Guelph study.

12 Apr 2021

Neurotechnology combined with saliva testing improves accuracy in measuring psychoactive effects of cannabis

A new study, released today in the scientific journal Advances in Therapy is providing critical evidence that neurotechnology combined with saliva testing can drastically reduce the likelihood of falsely determining cannabis impairment due to THC residual detection.

7 Apr 2021

Chronic cannabis use associated with higher complication rates after spine surgery

For patients undergoing spinal surgery, the diagnosis of cannabis use disorder is associated with higher complication rates, including substantially increased risks of stroke and respiratory complications, reports a study in Spine.

3 Apr 2021

Naloxone can save lives but stigma is preventing its use among newly abstinent opioid users

Opioids are the main driver of fatal drug overdoses in the United States, according to the Centers for Disease Control and Prevention, resulting in 46,802 deaths in 2018, usually because the person stops breathing.

26 Mar 2021

FDA warns two companies for illegal marketing of unapproved CBD products

The U.S. Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).

22 Mar 2021

Inherited behaviors, traits that appear during adolescence may be related to adult cannabis use

While some youth experiment with marijuana but don't go on to long-term use, others develop a problematic pot habit that continues into adulthood.

22 Mar 2021

New discovery may prove vital to future research on medical cannabis

Medical cannabis is a subject of much debate. There is still a lot we do not know about cannabis, but researchers from the Department of Neuroscience at the Faculty of Health and Medical Sciences have made a new discovery that may prove vital to future research into and treatment with medical cannabis.

19 Mar 2021

Opioid use is linked with other forms of substance misuse, mental health problems

Opioid use has dramatically increased in the 21st century, especially among young adults. A new study from the University of Illinois provides insights on usage patterns among Illinois high school students to help inform prevention and treatment strategies.

19 Mar 2021

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells

Researchers in the United States have conducted a study showing that a cannabis plant compound inhibited infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human lung cells.

14 Mar 2021

Sharp declines in opioid production costs could reduce the price per dose

The legalization of cannabis and the arrival of nonmedical fentanyl are fundamentally changing drug markets in North America.

11 Mar 2021

Combining terpenes and cannabidiol may be highly active against human coronaviruses

A group of researchers from a well-known technology company in Israel showed a significant antiviral effect of a combination of terpenes and cannabidiol against a human coronavirus strain 229E. This exciting and first-of-its-kind report is currently available on the bioRxiv preprint server.

4 Mar 2021

How Ecodyst’s Modern Rotovap Revolutionizes Rotovap Technology

In this interview, NewsMed talks to George Adjabeng about the revolutionary new rotovap, Ecodyst Hydrogen, and how it supersedes traditional rotovap models,

From Ecodyst 4 Mar 2021

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.

23 Feb 2021

Researchers expand understanding of hop genome with implications for brewing industry

Oregon State University and U.S. Department of Agriculture researchers have significantly expanded the understanding of the hop genome, a development with important implications for the brewing industry and scientists who study the potential medical benefits of hops.

22 Feb 2021

Wastewater analysis shows the pattern of designer drug use in eight countries

Despite deaths and hospitalizations linked to many new psychoactive substances (NPS), an international wastewater study led by the University of South Australia shows just how prevalent 'party pills' and 'bath salts' are in different parts of the world.